Clinical Trial

Non-invasive Functional Assessment and Pathogenesis of Morquio A

Study acronym: NIFAMA
Recruiting
View on ClinicalTrials.gov →
Summary
Morquio A disease is a devastating systemic skeletal disease in which detailed progression and pathogenesis remain unknown. The proposed project aims to establish a non-invasive objective assessment that can be applicable to all ages of patients to better understand the progress of their disease and the most serious clinical problems (cervical instability and stenosis, tracheal obstruction, hyperlaxity of joints, hip dysplasia, and small lung capacity). The outcome of this project will lead to a more precise understanding of the skeletal/pulmonary compromise and defining clinical endpoints in this disease for future clinical trials of current or developing therapies.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-03-09; most recent amendment 2026-05-11.
Trial Details
NCT Number NCT05284006
Lead Sponsor Nemours Children's Clinic
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Mucopolysaccharidosis IV Type A, Morquio A Syndrome, MPS IVA
Enrollment 60 participants
Start Date 2021-05-01
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-13